Do changes to Quality and Outcomes Framework diabetes clinical indicators affect care as measured in the National Diabetes Audit?

Gadsby, Roger; Young, Bob

doi:10.1111/dme.13182

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NHS Digital publishes annual prescribing data, including British National Formulary (BNF) codes [7,8]. Together, these data provide an opportunity to investigate whether there are systematic associations between HbA 1c levels in people with Type 1 diabetes and practice-level population characteristics, diabetes service levels and use of medication.…”

Section: Introductionmentioning

confidence: 99%

Route to improving Type 1 diabetes mellitus glycaemic outcomes: real‐world evidence taken from the National Diabetes Audit

et al. 2017

Self Cite

View full text Add to dashboard Cite

Aim To use general practice-level data for England, available through the National Diabetes Audit, and primary care prescribing data to identify prescription treatment factors associated with variations in achieved glucose control (HbA 1c ).Methods General practice-level National Diabetes Audit data on Type 1 diabetes, including details of population characteristics, services, proportion of people achieving target glycaemic control [HbA 1c ≤58 mmol/mol (7.5%)] and proportion of people at high glycaemic risk [HbA 1c >86 mmol/ml (10%)], were linked to 2013-2016 primary care diabetes prescribing data on insulin types and blood glucose monitoring for all people with diabetes.

show abstract

Section: Introductionmentioning

confidence: 99%